BVF INC/IL Diversified Active

CIK: 0001056807 · Show all filings

Period: Q2 2016 (← Previous) (Next →)

Filing Date: Aug 15, 2016

Total Value ($000): $469,389 (92.8% shares, 7.2% debt)

Holdings (34)

— BLUEPRINT MEDICINES CORP 12.5%

Value ($000) $58,629 Shares 2,895,251 Est. Cost $24.64 Unrealized —

CYTK CYTOKINETICS INC 10.1%

Value ($000) $47,348 Shares 4,989,218 Est. Cost $7.03 Unrealized +16.7%

— CHEMOCENTRYX INC 7.8%

Value ($000) $36,737 Shares 8,182,052 Est. Cost $8.96 Unrealized —

— EXELIXIS INC 7.2%

Value ($000) $33,935 Shares 22,822,778 Est. Cost $0.84 Unrealized —

— CONCERT PHARMACEUTICALS INC 6.6%

Value ($000) $30,942 Shares 2,755,318 Est. Cost $13.78 Unrealized —

— ARRAY BIOPHARMA INC 6.3%

Value ($000) $29,409 Shares 8,260,897 Est. Cost $4.28 Unrealized —

— FORWARD PHARMA A/S 5.5%

Value ($000) $25,885 Shares 1,424,611 Est. Cost $20.85 Unrealized —

IONS IONIS PHARMACEUTICALS INC 4.2%

Value ($000) $19,797 Shares 850,000 Est. Cost $32.26 Unrealized 0.0%

— GLYCOMIMETICS INC 3.8%

Value ($000) $17,793 Shares 2,447,415 Est. Cost $7.27 Unrealized —

— CASCADIAN THERAPEUTICS INC 3.8%

Value ($000) $17,730 Shares 18,799,368 Est. Cost $0.94 Unrealized —

— ONCOMED PHARMACEUTICALS INC 3.5%

Value ($000) $16,487 Shares 1,339,336 Est. Cost $18.86 Unrealized —

— TOBIRA THERAPEUTICS INC 3.4%

Value ($000) $15,743 Shares 1,253,401 Est. Cost $16.80 Unrealized —

— CTI BIOPHARMA CORP 3.2%

Value ($000) $15,231 Shares 44,796,940 Est. Cost $1.27 Unrealized —

— ARQULE INC 3.0%

Value ($000) $14,155 Shares 7,450,128 Est. Cost $1.87 Unrealized —

XENE XENON PHARMACEUTICALS INC 2.2%

Value ($000) $10,511 Shares 1,775,572 Est. Cost $10.53 Unrealized -34.9%

— NIVALIS THERAPEUTICS INC 1.9%

Value ($000) $8,862 Shares 1,926,443 Est. Cost $6.47 Unrealized —

— VITAE PHARMACEUTICALS INC 1.7%

Value ($000) $8,212 Shares 761,079 Est. Cost $10.50 Unrealized —

— PARATEK PHARMACEUTICALS INC 1.7%

Value ($000) $7,998 Shares 575,000 Est. Cost $13.91 Unrealized —

INFIQ INFINITY PHARMACEUTICALS INC 1.5%

Value ($000) $6,896 Shares 5,184,600 Est. Cost $4.68 Unrealized 0.0%

— GTX INC DEL 1.3%

Value ($000) $6,332 Shares 11,512,000 Est. Cost $0.72 Unrealized —

CTMX CYTOMX THERAPEUTICS INC 1.3%

Value ($000) $6,192 Shares 606,138 Est. Cost $15.82 Unrealized -27.9%

— ADURO BIOTECH INC 1.2%

Value ($000) $5,809 Shares 513,603 Est. Cost $11.31 Unrealized —

MGNX MACROGENICS INC 1.2%

Value ($000) $5,398 Shares 200,000 Est. Cost $22.55 Unrealized 0.0%

ESPR ESPERION THERAPEUTICS INC NE 1.1%

Value ($000) $4,932 Shares 499,142 Est. Cost $16.09 Unrealized +3.0%

— PAIN THERAPEUTICS INC 1.0%

Value ($000) $4,708 Shares 2,149,913 Est. Cost $1.85 Unrealized —

— QLT INC 0.7%

Value ($000) $3,203 Shares 2,255,476 Est. Cost $3.61 Unrealized —

— SUNESIS PHARMACEUTICALS INC 0.6%

Value ($000) $2,636 Shares 4,813,294 Est. Cost $0.85 Unrealized —

— OREXIGEN THERAPEUTICS INC 0.5%

Value ($000) $2,258 Shares 5,252,100 Est. Cost $0.43 Unrealized —

— MAST THERAPEUTICS INC 0.4%

Value ($000) $1,738 Shares 3,696,961 Est. Cost $0.56 Unrealized —

— CATALYST BIOSCIENCES INC 0.3%

Value ($000) $1,476 Shares 970,948 Est. Cost $4.66 Unrealized —

GBIM GLOBEIMMUNE INC 0.3%

Value ($000) $1,276 Shares 657,653 Est. Cost $6.22 Unrealized -71.5%

— CALITHERA BIOSCIENCES INC 0.1%

Value ($000) $450 Shares 121,400 Est. Cost $5.43 Unrealized —

— PIERIS PHARMACEUTICALS INC 0.1%

Value ($000) $389 Shares 241,352 Est. Cost $1.61 Unrealized —

— AVIRAGEN THERAPEUTICS INC 0.1%

Value ($000) $292 Shares 208,353 Est. Cost $1.40 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	BLUEPRINT MEDICINES CORP	2,895,251	$58,629	12.5%	$24.64	—	COM	09627Y109
CYTK	CYTOKINETICS INC	4,989,218	$47,348	10.1%	$7.03	+16.7%	COM NEW	23282W605
—	CHEMOCENTRYX INC	8,182,052	$36,737	7.8%	$8.96	—	COM	16383L106
—	EXELIXIS INC	22,822,778	$33,935	7.2%	$0.84	—	NOTE 4.250% 8/1	30161QAC8
—	CONCERT PHARMACEUTICALS INC	2,755,318	$30,942	6.6%	$13.78	—	COM	206022105
—	ARRAY BIOPHARMA INC	8,260,897	$29,409	6.3%	$4.28	—	COM	04269X105
—	FORWARD PHARMA A/S	1,424,611	$25,885	5.5%	$20.85	—	SPONSORED ADR	34986J105
IONS	IONIS PHARMACEUTICALS INC	850,000	$19,797	4.2%	$32.26	0.0%	COM	462222100
—	GLYCOMIMETICS INC	2,447,415	$17,793	3.8%	$7.27	—	COM	38000Q102
—	CASCADIAN THERAPEUTICS INC	18,799,368	$17,730	3.8%	$0.94	—	COM	14740B101
—	ONCOMED PHARMACEUTICALS INC	1,339,336	$16,487	3.5%	$18.86	—	COM	68234X102
—	TOBIRA THERAPEUTICS INC	1,253,401	$15,743	3.4%	$16.80	—	COM	88883P101
—	CTI BIOPHARMA CORP	44,796,940	$15,231	3.2%	$1.27	—	COM	12648L106
—	ARQULE INC	7,450,128	$14,155	3.0%	$1.87	—	COM	04269E107
XENE	XENON PHARMACEUTICALS INC	1,775,572	$10,511	2.2%	$10.53	-34.9%	COM	98420N105
—	NIVALIS THERAPEUTICS INC	1,926,443	$8,862	1.9%	$6.47	—	COM	65481J109
—	VITAE PHARMACEUTICALS INC	761,079	$8,212	1.7%	$10.50	—	COM	92847N103
—	PARATEK PHARMACEUTICALS INC	575,000	$7,998	1.7%	$13.91	—	COM	699374302
INFIQ	INFINITY PHARMACEUTICALS INC	5,184,600	$6,896	1.5%	$4.68	0.0%	COM	45665G303
—	GTX INC DEL	11,512,000	$6,332	1.3%	$0.72	—	COM	40052B108
CTMX	CYTOMX THERAPEUTICS INC	606,138	$6,192	1.3%	$15.82	-27.9%	COM	23284F105
—	ADURO BIOTECH INC	513,603	$5,809	1.2%	$11.31	—	COM	00739L101
MGNX	MACROGENICS INC	200,000	$5,398	1.2%	$22.55	0.0%	COM	556099109
ESPR	ESPERION THERAPEUTICS INC NE	499,142	$4,932	1.1%	$16.09	+3.0%	COM	29664W105
—	PAIN THERAPEUTICS INC	2,149,913	$4,708	1.0%	$1.85	—	COM	69562K100
—	QLT INC	2,255,476	$3,203	0.7%	$3.61	—	COM	746927102
—	SUNESIS PHARMACEUTICALS INC	4,813,294	$2,636	0.6%	$0.85	—	COM NEW	867328601
—	OREXIGEN THERAPEUTICS INC	5,252,100	$2,258	0.5%	$0.43	—	COM	686164104
—	MAST THERAPEUTICS INC	3,696,961	$1,738	0.4%	$0.56	—	COM	576314108
—	CATALYST BIOSCIENCES INC	970,948	$1,476	0.3%	$4.66	—	COM	14888D109
GBIM	GLOBEIMMUNE INC	657,653	$1,276	0.3%	$6.22	-71.5%	COM	37957B100
—	CALITHERA BIOSCIENCES INC	121,400	$450	0.1%	$5.43	—	COM	13089P101
—	PIERIS PHARMACEUTICALS INC	241,352	$389	0.1%	$1.61	—	COM	720795103
—	AVIRAGEN THERAPEUTICS INC	208,353	$292	0.1%	$1.40	—	COM	053761102